Local Institution - 0084

Madrid 28040

2 studies enrolling now · 4 studies all time

What they study most

Cancer, Hepatocellular, Hodgkin Disease, Irritability Associated With Autism Spectrum Disorder, Pulmonary Fibrosis

Studies at this site

• Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis — Starting soon
• A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder — Starting soon
• A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment — Completed
• A Study of Nivolumab and Ipilimumab and Nivolumab Alone in Combination With Trans-arterial ChemoEmbolization (TACE) in Participants With Intermediate Stage Liver Cancer — Completed